sumatriptan has been researched along with Autistic Disorder in 2 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Autistic Disorder: A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To sort out this heterogeneity in autism, we investigated whether specific neurobiological markers vary in parallel to core symptomatology." | 6.69 | The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder. ( Allen, A; Aronowitz, B; Cartwright, C; DeCaria, C; Hollander, E; Novotny, S, 2000) |
| "In this study, 11 adult patients with autism or Asperger's disorder were compared with nine matched controls." | 6.69 | Increased growth hormone response to sumatriptan challenge in adult autistic disorders. ( Allen, A; Aronowitz, B; Cartwright, C; DeCaria, C; Dolgoff-Kaspar, R; Hollander, E; Mosovich, S; Novotny, S, 2000) |
| "To sort out this heterogeneity in autism, we investigated whether specific neurobiological markers vary in parallel to core symptomatology." | 2.69 | The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder. ( Allen, A; Aronowitz, B; Cartwright, C; DeCaria, C; Hollander, E; Novotny, S, 2000) |
| "In this study, 11 adult patients with autism or Asperger's disorder were compared with nine matched controls." | 2.69 | Increased growth hormone response to sumatriptan challenge in adult autistic disorders. ( Allen, A; Aronowitz, B; Cartwright, C; DeCaria, C; Dolgoff-Kaspar, R; Hollander, E; Mosovich, S; Novotny, S, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hollander, E | 2 |
| Novotny, S | 2 |
| Allen, A | 2 |
| Aronowitz, B | 2 |
| Cartwright, C | 2 |
| DeCaria, C | 2 |
| Mosovich, S | 1 |
| Dolgoff-Kaspar, R | 1 |
2 trials available for sumatriptan and Autistic Disorder
| Article | Year |
|---|---|
The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder.
Topics: Adolescent; Adult; Autistic Disorder; Compulsive Behavior; Human Growth Hormone; Humans; Middle Aged | 2000 |
Increased growth hormone response to sumatriptan challenge in adult autistic disorders.
Topics: Adolescent; Adult; Autistic Disorder; Female; Human Growth Hormone; Humans; Male; Middle Aged; Recep | 2000 |